Lewis-Hall Freda C
Executive Vice President at PFE; EVP, Medicines Development at VRTX
- Sold, on record
- $1.2M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Sep 16, 2013
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale VRTXPlan not statedDec 11, 2008 2008
Sold 1,250 shares at $26.00 ($33k)
Lewis-Hall Freda C, EVP, Medicines Development
Sold 2.8% of holdings ($1.2M position)43,750 shares leftFirst sale on recordFiling
- 2 Form 4 sale VRTXPlan not statedDec 19, 2008 +8 days
Sold 1,250 shares at $29.90 ($37k)
Lewis-Hall Freda C, EVP, Medicines Development
Sold 2.9% of holdings ($1.3M position)42,500 shares leftFiling
- 3 Form 4 sale VRTXPlan not statedMar 19, 2009 +90 days
Sold 1,250 shares at $29.11 ($36k)
Lewis-Hall Freda C, EVP, Medicines Development
Sold 2.3% of holdings ($1.6M position)53,334 shares leftFiling
- 4 Form 4 sale PFEPlan not statedSep 16, 2013 +1642 days
Sold 38,461 shares at $28.70 ($1.1M)
Lewis-Hall Freda C, Executive Vice President
Sold 24.5% of holdings ($4.5M position)118,383 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2013 | Sep 18, 2013 | PFE | Executive Vice President | Form 4 sale | 38,461 | $1.1M | 24.5% | Plan not stated | SEC |
| Mar 19, 2009 | Mar 20, 2009 | VRTX | EVP, Medicines Development | Form 4 sale | 1,250 | $36k | 2.3% | Plan not stated | SEC |
| Dec 19, 2008 | Dec 22, 2008 | VRTX | EVP, Medicines Development | Form 4 sale | 1,250 | $37k | 2.9% | Plan not stated | SEC |
| Dec 11, 2008 | Dec 12, 2008 | VRTX | EVP, Medicines Development | Form 4 sale | 1,250 | $33k | 2.8% | Plan not stated | SEC |